Pfizer: Obesity trials
The registry lists 64 Obesity studies with Pfizer as lead sponsor. 13 are open to participants now and 11 have results posted.
Phase 1 32Phase 2 14Phase 3 17No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- The Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightNot yet recruitingNCT07932925Phase 3
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)RecruitingNCT07919678Phase 3
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2 Diabetes (VESPER-OA 2)RecruitingNCT07915609Phase 3
- A Study to Learn How Different Forms of the Study Medicine Called Berobenatide is Taken up Into the Blood in Adults With Overweight or ObesityRecruitingNCT07876531Phase 1
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08656795 Are Tolerated and Act in Adults With Overweight or ObesityNot yet recruitingNCT07876518Phase 1
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Monthly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07874633Phase 3
- A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or ObesityRecruitingNCT07845500Phase 3
- A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)RecruitingNCT07823608Phase 3
- A Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)RecruitingNCT07794774Phase 3
- A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)RecruitingNCT07794761Phase 3
- A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityRecruitingNCT07792954Phase 3
- A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have ObesityRecruitingNCT07731139Phase 1
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruitingNCT07595549Phase 3
- A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or OverweightCompletedNCT06712836Phase 2Results posted
- A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or ObeseCompletedNCT05677867Phase 1Results posted
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity RangeTerminatedNCT05671653Phase 1Results posted
- Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With ObesityTerminatedNCT05579977Phase 2Results posted
- Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes MellitusCompletedNCT05158244Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With ObesityCompletedNCT04707313Phase 2Results posted
- Effectiveness And Safety Of Oral Anticoagulants Among Obese Patients With Non-Valvular A-Fib In VA Patients With MedicareCompletedNCT04681482Results posted
- Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With ObesityCompletedNCT04621227Phase 1Results posted
- A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITYCompletedNCT04617275Phase 2Results posted
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese SubjectsCompletedNCT03041792Phase 1Results posted
- Multiple Dose Study Of PF-05231023 In Obese Adult SubjectsTerminatedNCT01923389Phase 1Results posted
- A Study to Learn About the Study Medicine Called PF-08653944 in Otherwise Healthy Chinese Adults With Overweight or ObesityActive, not recruitingNCT07845513Phase 1
- A Study to Learn How the Study Medicine Called PF-08653945 is Taken up Into the Blood in Adults With Overweight or ObesityActive, not recruitingNCT07725809Phase 1
- A Study of PF-08653945 and PF-08653944 in Adults With Overweight or ObesityActive, not recruitingNCT07575932Phase 2
- A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Content in Healthy Adults With Overweight or ObesityActive, not recruitingNCT07508241Phase 1
- A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or ObesityCompletedNCT07400679Phase 1
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)Active, not recruitingNCT07400653Phase 3
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or ObesityActive, not recruitingNCT07311850Phase 3
- A Study of MET233 in Individuals With Obesity or OverweightCompletedNCT07022977Phase 1
- A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or OverweightCompletedNCT06973720Phase 2
- A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without DiabetesCompletedNCT06924320Phase 1/2
- Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or ObesityTerminatedNCT06910839Phase 1
- A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DMCompletedNCT06897202Phase 2
- This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or ObesityCompletedNCT06857617Phase 1/2
- A Study to Learn About the Study Medicine Called PF-07976016 in Adults With ObesityCompletedNCT06717425Phase 2
- A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or ObesityCompletedNCT06568731Phase 1
- A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or ObeseCompletedNCT06567327Phase 1
- A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes MellitusCompletedNCT06279234Phase 1
- STUDY TO COMPARE PHARMACOKINETICS (PK) OF SINGLE ORAL DOSES OF DIFFERENT PF-06882961 FORMULATIONS IN PARTICIPANTS WHO ARE OVERWEIGHT OR HAVE OBESITYCompletedNCT04616339Phase 1
- Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal WomenCompletedNCT02100553Phase 1
- A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese SubjectsWithdrawnNCT01472848Phase 1
- A Multiple Dose Study Of PF-04620110 In Overweight And Obese, Otherwise Healthy VolunteersCompletedNCT00959426Phase 1
- Effect of Diltiazem Administration on CP-945,598 PharmacokineticsCompletedNCT00645463Phase 1
- Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And SafetyCompletedNCT00645216Phase 1
- Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental DrugCompletedNCT00645021Phase 1
- Study Examing The Effect Of Omeprazole On Safety, Tolerability And How The Body Processes An Experimental DrugCompletedNCT00644839Phase 1
- Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic GallstonesCompletedNCT00576589Phase 1
- A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body WeightCompletedNCT00542009Phase 2
- A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese PatientsTerminatedNCT00483171Phase 3
- Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, VolunteersCompletedNCT00479492Phase 2
- Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental DrugCompletedNCT00472836Phase 1
- Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight LossCompletedNCT00471172Not applicable
- Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.TerminatedNCT00396448Phase 3
- A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic PatientsTerminatedNCT00391196Phase 3
- Methods Study to Characterize Early Indicators of Weight Loss in PeopleCompletedNCT00383253Not applicable
- Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033WithdrawnNCT00376285Phase 1
- A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And SafetyTerminatedNCT00375401Phase 3
- Safety, Toleration and Efficacy of CP-741,952 for the Treatment of ObesityTerminatedNCT00367783Phase 2
- Safety, Toleration and Pharmacokinetics of Single Intravenous Doses of Peptide YY in Overweight AdultsCompletedNCT00331175Phase 1
- Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric SyndromeTerminatedNCT00283374
- A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese SubjectsCompletedNCT00134199Phase 2/3